Position in NRXS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$861,176
-$2,596 QoQ
Shares Held
117,808
+0.9% QoQ
Ownership
0.951%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1
of 3 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NRXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PARSONS CAPITAL MANAGEMENT INC/RI holds $8,774,262 across 6 Biotechnology names. NRXS ranks #3 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,779 | $4,857,522 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
354,069 | $2,450,157 | |
| 3 | NRXS |
Neuraxis, INC
This page
|
117,808 | $861,176 | |
| 4 | TECH |
BIO-TECHNE Corp
|
6,712 | $474,202 | |
| 5 | MDXG |
Mimedx Group, Inc.
|
32,692 | $125,864 | |
| 6 | GTBP |
GT Biopharma, Inc.
|
10,900 | $5,341 |
All Filings in NRXS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $861,176 | 117,808 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $863,772 | 116,726 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $529,936 | 116,726 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $359,516 | 116,726 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $282,476 | 116,726 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $250,960 | 116,726 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $274,306 | 116,726 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $38,740 | 13,000 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $36,140 | 13,000 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $40,560 | 13,000 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $34,710 | 13,000 | Shares | Sole | 2024-01-22 | |
| No filing history on record for this holder in this stock. | ||||||